Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Carlisle Companies | CSL | Nov 27, 2024 | 457.59 | -0.79 |
Carlyle Credit Income Fund | CCIF | Nov 27, 2024 | 8.00 | -0.37 |
Carlyle Credit Income Fund | CCIA | Nov 27, 2024 | 26.00 | +0.12 |
Carlyle Secured Lending | CGBD | Nov 27, 2024 | 17.32 | +0.76 |
CarMax | KMX | Nov 27, 2024 | 84.59 | -0.59 |
Carmell | CTCX | Nov 27, 2024 | 0.28 | +6.11 |
Carnival | CCL | Nov 27, 2024 | 25.14 | -0.79 |
Carnival ADR | CUK | Nov 27, 2024 | 22.68 | -0.66 |
CarParts.com | PRTS | Nov 27, 2024 | 1.02 | -4.67 |
Carpenter Technology | CRS | Nov 27, 2024 | 194.46 | -0.86 |
Carriage Services | CSV | Nov 27, 2024 | 40.39 | +0.98 |
Carrier Global | CARR | Nov 27, 2024 | 76.90 | -0.05 |
Cars.com | CARS | Nov 27, 2024 | 19.70 | +0.20 |
Carter Bankshares | CARE | Nov 27, 2024 | 18.71 | -0.69 |
Carters | CRI | Nov 27, 2024 | 55.01 | +0.46 |
Cartesian Growth II A | RENE | Nov 27, 2024 | 11.64 | +0.17 |
Cartesian Growth II Unit | RENEU | Nov 27, 2024 | 11.38 | 0.00 |
Cartesian Therapeutics | RNAC | Nov 27, 2024 | 17.91 | -3.97 |
Cartica Acquisition A | CITE | Nov 27, 2024 | 11.65 | 0.00 |
Carvana | CVNA | Nov 27, 2024 | 254.97 | -0.40 |
Carver Bancorp | CARV | Nov 27, 2024 | 1.83 | +9.58 |
Casella Waste Systems A | CWST | Nov 27, 2024 | 112.28 | +0.70 |
Caseys General Stores | CASY | Nov 27, 2024 | 420.98 | -1.29 |
CASI Pharmaceuticals | CASI | Nov 27, 2024 | 3.97 | -4.11 |
Cass Information Systems | CASS | Nov 27, 2024 | 44.60 | +0.13 |
Cassava Sciences | SAVA | Nov 27, 2024 | 3.98 | +4.05 |
Castellum | CTM | Nov 27, 2024 | 0.20 | +21.96 |
Castle Biosciences | CSTL | Nov 27, 2024 | 30.44 | -0.43 |
Castor Maritime | CTRM | Nov 27, 2024 | 3.50 | +0.72 |
Catalent | CTLT | Nov 27, 2024 | 61.00 | +0.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.